|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2005-5-19
|
|
pubmed:abstractText |
Current treatment for primary central nervous system lymphoma (PCNSL) involves high-dose methotrexate (HDMTX) with or without radiotherapy. Many published studies describing this approach include a highly selected group of patients. We report a single-centre experience of unselected cases of PCNSL.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0936-6555
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
185-91
|
|
pubmed:dateRevised |
2008-3-10
|
|
pubmed:meshHeading |
pubmed-meshheading:15901003-Adult,
pubmed-meshheading:15901003-Aged,
pubmed-meshheading:15901003-Aged, 80 and over,
pubmed-meshheading:15901003-Antimetabolites, Antineoplastic,
pubmed-meshheading:15901003-Central Nervous System Neoplasms,
pubmed-meshheading:15901003-Female,
pubmed-meshheading:15901003-Humans,
pubmed-meshheading:15901003-Lymphoma,
pubmed-meshheading:15901003-Male,
pubmed-meshheading:15901003-Methotrexate,
pubmed-meshheading:15901003-Middle Aged,
pubmed-meshheading:15901003-Retrospective Studies,
pubmed-meshheading:15901003-Survival Analysis,
pubmed-meshheading:15901003-Treatment Outcome
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Primary central nervous system lymphoma: a single-centre experience of 55 unselected cases.
|
|
pubmed:affiliation |
Department of Haematology, Addenbrooke's Hospital, Cambridge, UK. daniel.hodson@nnuh.nhs.uk
|
|
pubmed:publicationType |
Journal Article
|
